Cargando…

Toxinotyping and Sequencing of Clostridium difficile Isolates from Patients in a Tertiary Care Hospital of Northern India

BACKGROUND: Clostridium difficile is an important cause of infectious colitis among hospitalized patients across the globe. The pathogenic potential of C. difficile in producing significant morbidity and mortality is mainly due to production of toxins A and B. The outbreaks of C. difficile infection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Meenakshi, Vaishnavi, Chetana, Mahmood, Safrun, Kochhar, Rakesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368245/ https://www.ncbi.nlm.nih.gov/pubmed/28401147 http://dx.doi.org/10.3389/fmed.2017.00033

Ejemplares similares

Toxigenic Clostridium difficile isolates from clinically significant diarrhoea in patients from a tertiary care centre
por: Singh, Meenakshi, et al.
Publicado: (2017)

Susceptibility of Hamsters to Clostridium difficile Isolates of Differing Toxinotype
por: Buckley, Anthony M., et al.
Publicado: (2013)

Toxinotype V Clostridium difficile in Humans and Food Animals
por: Jhung, Michael A., et al.
Publicado: (2008)

Clostridium difficile Ribotype 027, Toxinotype III, the Netherlands
por: Kuijper, Ed J., et al.
Publicado: (2006)

Pancreatic disease patients are at higher risk for Clostridium difficile infection compared to those with other co-morbidities
por: Vaishnavi, Chetana, et al.
Publicado: (2019)

Effect of Lactobacillus acidophilus & epidermal growth factor on experimentally induced Clostridium difficile infection
por: Kaur, Sukhminderjit, et al.
Publicado: (2011)

Fidaxomicin - the new drug for Clostridium difficile infection
por: Vaishnavi, Chetana
Publicado: (2015)

Pathogenicity locus determinants and toxinotyping of Clostridioides difficile isolates recovered from Iranian patients
por: Aliramezani, A., et al.
Publicado: (2018)

Toxinotyping and Antimicrobial Resistance of Clostridium Perfringens Isolated from Processed Chicken Meat Products
por: Hamza, Dalia, et al.
Publicado: (2017)

Phenotypical Identification and Toxinotyping of Clostridium perfringens Isolates from Healthy and Enteric Disease-Affected Chickens
por: Rana, Eaftekhar Ahmed, et al.
Publicado: (2023)

A calf with hind limb paralysis and dysstasia and a genome sequence analysis of an isolated Clostridium perfringens toxinotype E strain
por: MADA, Takashi, et al.
Publicado: (2023)

Comparative genomics of Clostridioides difficile toxinotypes identifies module-based toxin gene evolution
por: Janezic, Sandra, et al.
Publicado: (2020)

Prevalence and characterization of Clostridium perfringens toxinotypes among patients with antibiotic-associated diarrhea in Iran
por: Azimirad, Masoumeh, et al.
Publicado: (2019)

Large-Scale Genomic Analyses and Toxinotyping of Clostridium perfringens Implicated in Foodborne Outbreaks in France
por: Mahamat Abdelrahim, Abakabir, et al.
Publicado: (2019)

Genomic Analysis of Clostridium perfringens BEC/CPILE-Positive, Toxinotype D and E Strains Isolated from Healthy Children
por: Kiu, Raymond, et al.
Publicado: (2019)

Erratum: Large-Scale Genomic Analyses and Toxinotyping of Clostridium perfringens Implicated in Foodborne Outbreaks in France
Publicado: (2019)

Characterization of biofilms in biliary stents and potential factors involved in occlusion
por: Vaishnavi, Chetana, et al.
Publicado: (2018)

TCF 4 tumor suppressor: a molecular target in the prognosis of sporadic colorectal cancer in humans
por: Anwar, Mumtaz, et al.
Publicado: (2020)

Novel Antimicrobials for the Treatment of Clostridium difficile Infection
por: Petrosillo, Nicola, et al.
Publicado: (2018)

Clostridium perfringens Associated with Foodborne Infections of Animal Origins: Insights into Prevalence, Antimicrobial Resistance, Toxin Genes Profiles, and Toxinotypes
por: Bendary, Mahmoud M., et al.
Publicado: (2022)

Clostridium difficile Infection
por: Feuerstadt, Paul
Publicado: (2015)

Antibiotics Associated With Clostridium difficile Infection
por: Rafey, Abdur, et al.
Publicado: (2023)

Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China
por: Dai, Wei, et al.
Publicado: (2020)

Risk Factors Associated With Clostridium difficile-Associated Diarrhea
por: Gupta, Aarzoo, et al.
Publicado: (2021)

Clostridium difficile infections in teaching hospital in northern Finland
por: Marttila-Vaara, M., et al.
Publicado: (2019)

Clostridium difficile Infection: Risk and Poor Prognostic Factors at a Tertiary Hospital in the Eastern Region of Saudi Arabia
por: Miqdad, Mohammed A, et al.
Publicado: (2023)

Changing trends of clostridium difficile associated diarrhoea (cdad) in a tertiary care hospital in kolkata, india
por: Chakraborty, A, et al.
Publicado: (2015)

Molecular, microbiological and clinical characterization of Clostridium difficile isolates from tertiary care hospitals in Colombia
por: Salazar, Clara Lina, et al.
Publicado: (2017)

An Unusual Presentation of Severe Sepsis Due to Clostridium difficile Enteritis
por: Abid, Haisam, et al.
Publicado: (2019)

The Impact of Appendectomy in Clostridium difficile Infection and Length of Hospital Stay
por: Essrani, Rajesh, et al.
Publicado: (2020)

Atypical Hemolytic Uremic Syndrome Associated With Clostridium Difficile Infection
por: Khurshid, Qasim, et al.
Publicado: (2020)

Rifaximin Therapy for Patients With Metronidazole-Unresponsive Clostridium difficile Infection
por: Waqas, Muhammad, et al.
Publicado: (2022)

Ischemic Colitis Is a Risk Factor for Clostridium difficile Infection
por: Khazaaleh, Shrouq, et al.
Publicado: (2022)

Antimicrobial susceptibility of Clostridium difficile isolated in Thailand
por: Putsathit, Papanin, et al.
Publicado: (2017)

A Case of Concomitant Emphysematous Cystitis and Clostridium difficile Colitis with Pneumoperitoneum
por: Tariq, Tooba, et al.
Publicado: (2018)

Probiotics and Clostridium Difficile: A Review of Dysbiosis and the Rehabilitation of Gut Microbiota
por: Kalakuntla, Ashish S, et al.
Publicado: (2019)

Clostridium Difficile and Noncirrhotic Hyperammonnemia in a Patient With COVID-19 Infection
por: Ramalingam, Sathishkumar, et al.
Publicado: (2021)

The Efficacy of Bezlotoxumab in the Prevention of Recurrent Clostridium difficile: A Systematic Review
por: Thandavaram, Abhay, et al.
Publicado: (2022)

Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China
por: Wang, Baoya, et al.
Publicado: (2018)

Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection
por: Shin, Saeam, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_huulj7tcbuhdkitbbmn7g4sbe6